Lin Shin-Yu, Su Yi-Ning, Hung Chia-Cheng, Tsay Woei, Chiou Shyh-Shin, Chang Chieh-Ting, Ho Hong-Nerng, Lee Chien-Nan
Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan.
BMC Med Genet. 2008 Jun 20;9:53. doi: 10.1186/1471-2350-9-53.
Hemophilia A represents the most common and severe inherited hemorrhagic disorder. It is caused by mutations in the F8 gene, which leads to a deficiency or dysfunctional factor VIII protein, an essential cofactor in the factor X activation complex.
We used long-distance polymerase chain reaction and denaturing high performance liquid chromatography for mutation scanning of the F8 gene. We designed the competitive multiplex PCR to identify the carrier with exonal deletions. In order to facilitate throughput and minimize the cost of mutation scanning, we also evaluated a new mutation scanning technique, high resolution melting analysis (HRM), as an alternative screening method.
We presented the results of detailed screening of 122 Taiwanese families with hemophilia A and reported twenty-nine novel mutations. There was one family identified with whole exons deletion, and the carriers were successfully recognized by multiplex PCR. By HRM, the different melting curve patterns were easily identified in 25 out of 28 cases (89%) and 15 out of 15 (100%) carriers. The sensitivity was 93 % (40/43). The overall mutation detection rate of hemophilia A was 100% in this study.
We proposed a diagnostic strategy for hemophilia A genetic diagnosis. We consider HRM as a powerful screening tool that would provide us with a more cost-effective protocol for hemophilia A mutation identification.
甲型血友病是最常见且严重的遗传性出血性疾病。它由F8基因突变引起,该突变导致凝血因子VIII蛋白缺乏或功能异常,而凝血因子VIII蛋白是凝血因子X激活复合物中的一种必需辅因子。
我们使用长距离聚合酶链反应和变性高效液相色谱法对F8基因进行突变扫描。我们设计了竞争性多重聚合酶链反应来鉴定外显子缺失的携带者。为了提高通量并最小化突变扫描成本,我们还评估了一种新的突变扫描技术——高分辨率熔解分析(HRM),作为一种替代筛选方法。
我们展示了对122个台湾甲型血友病家庭进行详细筛查的结果,并报告了29个新突变。有一个家庭被鉴定为全外显子缺失,其携带者通过多重聚合酶链反应成功识别。通过HRM,在28例中的25例(89%)和15例携带者中的15例(100%)中很容易识别出不同的熔解曲线模式。敏感性为93%(40/43)。本研究中甲型血友病的总体突变检测率为100%。
我们提出了一种甲型血友病基因诊断的策略。我们认为HRM是一种强大的筛选工具,它将为我们提供一种更具成本效益的甲型血友病突变鉴定方案。